PDE5A and urinary bladder carcinoma: Phosphodiesterase 5 (PDE5) is highly expressed in a variety of malignant tumors, such as bladder cancer, breast cancer, non-small cell lung cancer, and colorectal cancer, indicating that PDE5 plays an important role in tumorigenesis and that inhibition of PDE5 activity may have antitumor effects [10, 11].